The progression of multiple sclerosis (MS) can usually be slowed down with medication, but a cure is currently not possible. It is now established that Epstein-Barr virus is involved in the development of MS. However, it is not known how the pathogen triggers the disease. The European Union is now funding the international research consortium BEHIND-MS as part of its HORIZON Europe programme, which aims to clarify these associations in order to identify specific biomarkers and targeted therapeutic approaches. The consortium, led by the German Cancer Research Center, will receive 7.1 million …


Read More


Notizie del Consiglio Nazionale delle Ricerche

Dichiarazione di accessibilità

Note Legali

Privacy Policy